What is the current share price of Influx Healthtech Limited (INFLUX)?

As of the latest market update, Influx Healthtech Limited (INFLUX) is trading at ₹238.15. The stock has moved 1.02% down in the recent session.

What is the technical sentiment for INFLUX stock?

Based on our proprietary technical analysis, the current signal for INFLUX is "SELL". This analysis considers over 20+ indicators including RSI, MACD, and moving average crossovers to gauge market momentum.

What is the 52-week high and low for Influx Healthtech Limited?

Influx Healthtech Limited has seen a 52-week high of ₹298.75 and a 52-week low of ₹192.1. Comparing the current price to these levels helps investors understand the stock's relative valuation and volatility over the past year.

Which sector does Influx Healthtech Limited belong to?

Influx Healthtech Limited operates in the Healthcare sector, specifically within the Pharmaceuticals & Biotechnology industry. Its performance is often influenced by broader trends in the Healthcare segment.

What is the market capitalization of INFLUX?

Influx Healthtech Limited (INFLUX) has a market capitalization of approximately ₹551 Cr. This classifies it as a small cap stock in the Indian market.

INFLUX

NSE

Influx Healthtech Limited (SMALL CAP)

Healthcare>Healthcare>Pharmaceuticals & Biotechnology>Pharmaceuticals

₹238.15

2.45 (1.02%)

As on 12 Jun 2026

Advanced Chart

Price History

Market Cap

The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.

₹551 Cr

SMALL CAP

P/E Ratio

Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.

18.2

Industry

The specific business sector the company operates in. Useful for comparing with similar companies.

Pharmaceuticals

52-Week Range

The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.

52W Low₹192.1+24.0%

52W High₹298.75-20.3%

Current Price

₹238.15

Circuit Limits (20%)

The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.

Lower Circuit₹190.52

Upper Circuit₹285.78

Reference Price

₹238.15

Investment Checklist

Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹207.9

Triple Bottom on 1D (BREAKOUT CONFIRMED) — target ₹199.2

Trend: Price below most MAs — downtrend | Bearish MA stack (20<50<200)

20/50 Bearish Cross detected 3 day(s) ago

EMA(9) Crossover: Price crossed below EMA(9): Fresh bearish weakness signal.

Technical Analysis

Analysis from 2026-06-12

Confidence

48%

Trend

BEARISH

Price below most MAs — downtrend | Bearish MA stack (20<50<200)

EMA20

245.01

EMA50

259.54

EMA200

505.03

Price Action

MIXED

NEUTRAL

Higher Highs2

Higher Lows4

Lower Highs6

Lower Lows5

Support & Resistance Levels

Resistance (Above)

₹240.65

₹248.00

₹261.95

₹288.67

₹298.75

Support (Below)

₹234.98

₹228.30

₹224.00

₹209.00

₹199.50

Volume Analysis

TrendDECREASING

Change-67.20%

Unusual VolumeNo

Recent MA Crossovers

20/50 Bearish Cross

3 days ago

SELL

Stop Loss Levels

Fixed Risk

1% Risk₹235.77

3% Risk₹231.01

5% Risk₹226.24

7% Risk (Custom)

₹221.48

Technical Levels

1x ATR (Volatility)₹223.01

2x ATR (Swing)₹207.87

3x ATR (Trend)₹192.73

Immediate Support₹234.98

Financials

Financial data not available

Peer Comparison

Pharmaceuticals

Peer Comparison

Symbol	Name	Price	Change
SUNPHARMA	Sun Pharmaceutical Industries Limited	₹1,807.70	+0.75%
DIVISLAB	Divi's Laboratories Limited	₹6,638.00	-0.26%
TORNTPHARM	Torrent Pharmaceuticals Limited	₹4,571.20	-0.02%
CIPLA	Cipla Limited	₹1,389.40	+0.44%
ZYDUSLIFE	Zydus Lifesciences Limited	₹1,104.70	-0.11%
DRREDDY	Dr. Reddy's Laboratories Limited	₹1,275.40	-0.05%
LUPIN	Lupin Limited	₹2,293.30	+0.88%
MANKIND	Mankind Pharma Limited	₹2,381.10	+0.35%
AUROPHARMA	Aurobindo Pharma Limited	₹1,472.80	+0.59%
LAURUSLABS	Laurus Labs Limited	₹1,394.30	+0.25%

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Announcements

Latest updates

View All

Date	Description	Link
05 Jun 2026	Disclosure under SEBI Takeover Regulations
26 May 2026	Analysts/Institutional Investor Meet/Con. Call Updates
23 May 2026	Analysts/Institutional Investor Meet/Con. Call Updates
21 May 2026	Press Release
21 May 2026	Investor Presentation

Board Meetings

Upcoming and past meetings

View All

Date	Purpose	Links
20 May 2026	Financial Results
20 May 2026	Board Meeting Intimation	XBRL
12 Nov 2025	Financial Results/Other business matters
12 Nov 2025	Board Meeting Intimation	XBRL

Corporate Events

Upcoming results & meetings

View All

No upcoming events found

We couldn't find any scheduled corporate actions for this symbol at the moment.

Latest News

News for INFLUX

View All

SpaceX IPO: How To Trade The World's Largest Ever Public Issue In Asia's Locked-Out Markets

positive

NDTV Profit 1d ago

SpaceX IPO: How To Trade The World's Largest Ever Public Issue In Asia's Locked-Out Markets

Companies linked to SpaceX have particularly attracted bets that a fresh influx of capital

AKCAPITARIHANTCAPCPCAPECAPINSUREGROWWCAPMINFLUXFinancial ServicesHealthcare

Read full story

CD rates may fall up to 100 bps as banks tap overseas deposits, loans

positive

ET Markets - Industry 2d ago

CD rates may fall up to 100 bps as banks tap overseas deposits, loans

Interest rates on short-term financial instruments like Certificates of Deposit are poised to decrease across India. This anticipated drop, estimated at 75-100 basis points by July, follows large public sector units and banks tapping overseas loans and deposits. This influx of foreign funds is expected to cool domestic yields and ease borrowing costs for businesses and the government.

ESGINFLUXJMFINANCILFinancial ServicesHealthcare

Read full story

Indian steelmakers grapple with resurgence of cheap Chinese imports

positive

ET Markets - Industry 12d ago

Indian steelmakers grapple with resurgence of cheap Chinese imports

Chinese steel exports to India surged in April, reaching a two-year peak. This influx of cheaper steel, including hot-rolled coils and stainless steel, worries domestic producers. Some imports are reportedly routed through Vietnam. India has become a net importer of steel, contrasting with previous periods. Rising demand from infrastructure and automotive sectors fuels this trend.

INFLUXSALSTEELHealthcareMetals & Mining

Read full story

INFLUX

Price History

Investment Checklist

Technical Analysis

Technical Analysis

Trend

Price Action

Support & Resistance Levels

Volume Analysis

Recent MA Crossovers

Stop Loss Levels

Fixed Risk

Technical Levels

Financials

Peer Comparison

Peer Comparison

Corporate Information

Large Deals

Announcements

Board Meetings

Corporate Events

Latest News

News for INFLUX

SpaceX IPO: How To Trade The World's Largest Ever Public Issue In Asia's Locked-Out Markets

CD rates may fall up to 100 bps as banks tap overseas deposits, loans

Indian steelmakers grapple with resurgence of cheap Chinese imports

Frequently Asked Questions

What is the current share price of Influx Healthtech Limited (INFLUX)?

What is the technical sentiment for INFLUX stock?

What is the 52-week high and low for Influx Healthtech Limited?

Which sector does Influx Healthtech Limited belong to?

What is the market capitalization of INFLUX?